Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06155032 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Rescue Endovascular Therapy for Progressive Acute Mild Ischemic Stroke With Large Vascular Occlusion

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Mar 31, 2026 to Dec 31, 2026
    • Study completion date: Jun 30, 2026 to Mar 30, 2027
    v10
  2. Primary completion date: Dec 30, 2025 to Mar 31, 2026
    • Study completion date: Mar 30, 2026 to Jun 30, 2026
    • Collaborators: 1 to 8
    v9
  3. Secondary endpoints: 6 to 8
    • Site details revised at 1 of 7 sites
    • Eligibility criteria shortened, about 3 words
    v8
  4. Study sites: 5 to 7v7
  5. Study sites: 3 to 5
    • Study description expanded, about 1 word
    v6
Show 4 earlier versionsHide 4 earlier versions
  1. Study sites: 2 to 3
    • Secondary endpoints: details revised at 2 of 6 entries
    • Study title shortened, about 1 word
    v5
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 15, 2024 to Jan 4, 2024
    • Site details revised at 2 of 2 sites
    v4
  3. Start date: Dec 8, 2023 to Jan 15, 2024v3
  4. Study sites: 1 to 2v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Endovascular therapy (EVT) added on best medical management is currently recommended in acute large vascular occlusion (LVO) stroke patients with National Institutes of Health Stroke Scale (NIHSS) score \>5. Thus, a sizeable fraction of patients with a minor stroke that do not undergo cerebrovascular screening may experience an early neurological deterioration (END) due to LVO, possibly leading to poor long-term functional outcome. However, whether these patients may still benefit from a rescue EVT is unknown, especially in a late window (\>24 hours). In this study, the investigators assume that best medical management plus EVT might be superior than best medical management alone in a late window for minor stroke patients who have experienced an LVO and END. The primary objective of the study was to establish the safety and efficacy of EVT in a late window for minor stroke patients in the anterior circulation who experienced an LVO and END.
Trial Details
NCT Number NCT06155032
Lead Sponsor First Affiliated Hospital of Wannan Medical College
Collaborators: The First Affiliated Hospital of Anhui Medical University, Xiangtan Central Hospital, The First Affiliated Hospital of Hainan Medical University, Huang Shan People's Hospital, Fuyang people's hospital, Linyi People's Hospital, Jiujiang No.1 People's Hospital, Taihe Hospital
Conditions
(from sponsor)		 Stroke, Ischemic, Cerebrovascular; Disorder, Occlusive
Related terms Bites and Stings, Ischemic Stroke
Enrollment 272 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov